The gene product of fabG from Aquifex aeolicus has been heterologously expressed in Escherichia coli. Purification of the protein took place using anionexchange and size-exclusion chromatography and the protein was then crystallized. Diffraction data were collected to a maximum resolution of 1.8 Å and the initial phases were determined by molecular replacement. The A. aeolicus FabG protein is a putative -ketoacyl-acyl carrier protein reductase. Structure-function studies of this protein are being performed as part of a larger project investigating naturally occurring deviations from highly conserved residues within the short-chain oxidoreductase (SCOR) family.
Introduction
The short-chain oxidoreductase (SCOR) enzyme family includes at least 300 biochemically characterized enzymes found in bacteria, plants, insects and mammals (Oppermann et al., 2003) . This ancient family possesses members that catalyze a diversity of reactions (i.e. oxidation, reduction, epimerization and synthase reactions) using a wide range of substrates (e.g. steroids, sugars, prostaglandins, alcohols, acids, aromatics, xenobiotics etc.) . SCOR proteins are known to participate in steroid metabolism, fatty-acid synthesis and clearance of toxins. Several are targets for drug development for the treatment of a variety of diseases (e.g. steroid-dependent cancers and bacterial infections). Over 13 500 putative members of the SCOR family have been identified through sequence similarity, but the vast majority have unknown substrates and functions and a significant number may have been incorrectly annotated. This large and diverse protein family does not contain a single amino-acid residue that is completely conserved in all SCOR members. Approximately 70% of the SCOR family belong to the TGxxxGIG subfamily, named after their signature sequence within the 12 turn of the embedded Rossmann fold (unpublished data).
The diversity of the SCOR family makes it ideal for developing methods for identifying specific sets of residues (fingerprints) useful for predicting the biological properties (e.g. cofactor-specificity, substrate-specificity, oligomeric state etc.) of the large number of experimentally uncharacterized proteins that have been putatively assigned to the family (Duax et al., 2003 (Duax et al., , 2005 . This fingerprinting methodology employs knowledge of both the sequence and the experimentally determined three-dimensional structure. To further refine the methodology and to test the predictions, additional SCOR crystal structures are required (i) to provide a representative crystal structure to fingerprint families thus far assigned by sequence alone, (ii) to investigate the effect of engineered mutations or natural variations within a fingerprint and (iii) to identify the structural and functional roles of specific residues. As part of this rational proteomics project, the gene product of fabG (locus aq_1716; SWISS-PROT/TrEMBL accession No. 067610) from the thermophile Aquifex aeolicus VF5 was chosen for structural studies.
A. aeolicus FabG (Aae FabG) contains 248 amino acids, with a calculated weight of 26.9 kDa per monomer. It has been annotated based upon sequence as being a -ketoacyl-acyl carrier protein reductase (-k-ACPR; also referred to as 3-oxoacyl acyl-carrierprotein reductase; EC 1.1.1.100) and participates in the fatty-acid biosynthesis pathway as a component of bacterial fatty-acid synthase II (FAS II; Rock & Jackowski, 2002) . The NADP(H)-dependent FabG reduces the acyl carrier protein-linked -ketoacyl group to a -hydroxyacyl group during the elongation of the fatty acid's acyl chain. However, there are no published reports of the biochemical and biophysical characterization of Aae FabG. The crystal structures of several FAS II -k-ACPRs have been determined (Fisher et al., 2000; Price et al., 2001 Price et al., , 2004 Wickramasinghe et al., 2006; Yang et al., 2002 Yang et al., , 2003 . These homologues have 42-51% amino-acid sequence identity to Aae FabG. Significantly, Aae FabG exhibits deviations at 10% (four out of 40) of the highly conserved SCOR TGxxxGIG fingerprint residues, with three of these variations resulting in a change in chemical properties (Asn65, Asp84, Thr159 and Val180 in Aae FabG; the fingerprint residues are Asp, Gly, Ala and Ile, respectively). In the previously determined crystal structures of FabG homologues, only the M. tuberculosis enzyme (Yang et al., 2002 (Yang et al., , 2003 exhibits any of these fingerprint deviations: a variation corresponding to the Ile to Val180 variation observed in Aae FabG. These data indicate that the A. aeolicus enzyme may possess unique properties, perhaps as a consequence of the stability requirements of the thermophile. Thus, Aae FabG is an attractive structural target for use in further refinement of the SCOR fingerprint methodology.
Experimental methods

Cloning
The fabG gene from A. aeolicus was amplified by polymerase chain reaction using genomic DNA as a template. The restriction-enzyme sites NdeI and XhoI were designed into the forward primer and reverse primer, respectively. The forward primer sequence was 5 0 -GCGCATATGGAAATAAAACTCCAGGG-3 0 and the reverse primer sequence was 5 0 -GCGCTCGAGTTAAAACATTCCTCCGT-TTAC-3 0 , with the restriction sites denoted in bold. The reverse primer also encodes the complement to a stop codon.
The amplified fabG fragment containing NdeI and XhoI restriction sites was ligated into the pGEM-T Easy vector (Promega) using T4 DNA ligase (Roche Applied Sciences) to create the T-fabG plasmid. DNA sequencing confirmed the fidelity of the amplified gene. The fabG fragment was excised from the T-fabG vector using NdeI and XhoI restriction enzymes and ligated into the pETDuet-1 expression vector (Novagen), previously digested with NdeI and XhoI, yielding pETDuet-fabG. This protocol produced a recombinant protein that has an identical amino-acid sequence to that of the wild-type protein, without any additional residues arising from the parental vector.
Expression and purification
The final pETDuet-fabG construct harboring A. aeolicus fabG was transformed into Escherichia coli Rosetta (DE3) strain (Novagen) for protein expression. Cells from an overnight 10 ml pre-culture were used to inoculate 1 l LB medium containing ampicillin (100 mg ml À1 ) and chloramphenicol (35 mg ml À1 ) at 310 K and 220 rev min À1 . Protein expression was induced with 1 mM isopropyl -d-thiogalactopyranoside (IPTG) when the culture reached an OD 600 of approximately 0.4-0.6 and the culture was incubated for 4-6 h prior to harvesting. The harvested cells were stored at 253 K.
The cell pellets were thawed and resuspended in 100 ml buffer A (50 mM Tris-HCl pH 8.0, 10 mM NaCl, 1 mM EDTA, 1 mM DTT) and 1 ml protease-inhibitor cocktail (Sigma). Cells were lysed by sonication. Whole cell lysate was then centrifuged at 35 000g for 60 min at 277 K. The supernatant was loaded onto a 5 ml HiTrap Q Sepharose Fast Flow anion-exchange column (Amersham Bio-sciences) equilibrated with buffer A. After washing the column with 20 column volumes (CV) of buffer A, the protein was eluted with a linear gradient (10-300 mM NaCl over 15 CV). The peak containing Aae FabG was pooled and diluted tenfold with buffer A to reduce the NaCl concentration. The sample was then loaded onto a Mono Q 10/10 anion-exchange column (Amersham Biosciences) equilibrated with buffer A. After washing with 10 CV buffer A, Aae FabG was eluted using a linear gradient of NaCl (10-300 mM over 10 CV). The peak containing Aae FabG was pooled and concentrated to 2 ml. The final purification step was size-exclusion chromatography (HiLoad 16/60 Superdex 200 column, Amersham Biosciences) using buffer B (50 mM Tris-HCl pH 8.0, 250 mM NaCl, 1 mM EDTA, 1 mM DTT). The peak containing Aae FabG was collected and concentrated to $10 mg ml À1 in buffer B for crystallization. SDS-PAGE was used to judge the purity of protein samples.
Crystallization
Initial crystallization screening of Aae FabG at 10 mg ml À1 in buffer B used a robotic 1536-condition microbatch-under-oil screen at 296 K (Luft et al., 2001) . Crystallization leads were identified in over 50 of the conditions. One initial condition [100 mM MES pH 6.0, 100 mM NH 4 Cl, 40%(v/v) PEG 400, with droplets containing 200 nl protein solution and 200 nl screen cocktail], which produced single crystals, was optimized using hanging-drop vapor diffusion to obtain crystals suitable for diffraction studies. The optimal conditions were 7 mg ml À1 protein and a reservoir solution consisting of 100 mM MES pH 6.0, 120 mM NH 4 Cl, 36%(v/v) PEG 400, with the crystallization drop containing 2 ml protein solution and 2 ml reservoir solution. The maximum dimensions of the crystals were 0.20 Â 0.10 Â 0.05 mm.
Diffraction data collection and processing
No additional cryoprotectant was required for preparation of the crystals for X-ray diffraction studies under cryoconditions as the PEG 400 in the mother liquor served this purpose. Crystals were mounted directly from the crystallization droplet in nylon loops (Hampton Research) and flash-cooled by plunging into liquid nitrogen. Diffraction data were collected at SSRL beamlines 9-1 and 11-1 via remote control using the Stanford Automated Mounting System and Blu-Ice control software (McPhillips et al., 2002) . Both beamlines were equipped with an ADSC Quantum-315 CCD detector. Data were processed using the HKL-2000 suite (Otwinowski & Minor, 1997) , yielding scaled intensities. Molecular replacement made use of the automated web service CaspR (Claude et al., 2004) .
Results and discussion
Aae FabG expressed well in E. coli Rosetta (DE3) cells and was completely soluble. The heterologously expressed protein possessed an amino-acid sequence identical to that of the wild-type protein, lacking any affinity tag. Thus, a low-resolution followed by a highresolution anion-exchange approach was utilized to purify the protein from the lysate supernatant, with a final gel-filtration step. The final yield of pure protein was approximately 15 mg per litre of culture and only a single band corresponding to the expected weight of Aae FabG was observed on SDS-PAGE (Fig. 1) .
Crystallization leads were obtained from a 1536-condition robotic microbatch-under-oil screen and were subsequently optimized by vapor diffusion. Initial attempts to collect diffraction data yielded modest-quality data to a maximum of 2.5 Å resolution (Table 1; crystal 1). However, the mosaicity was larger than desired ($1 ). These crystals grew in <24 h and it was likely that the fast growth resulted in a poorly ordered crystal lattice. Crystallization conditions were altered in order to slow nucleation and growth, leading to highquality crystals (Fig. 2 ) that diffracted to 1.8 Å resolution (Table 1; crystal 2). The diffraction data collected from all crystals studied were consistent with the orthorhombic crystal system, with unit-cell parameters a = 105.7, b = 63.6, c = 73.6 Å and systematic absences consistent with space group P2 1 2 1 2. The Matthews coefficient (Matthews, 1968 ) would be 4.6, 2.3 and 1.5 Å 3 Da À1 for one, two and three subunits of Aae FabG within the asymmetric unit, respectively. This result suggests the presence of two subunits per asymmetric unit.
Molecular-replacement (MR) techniques were applied to the 2.5 Å resolution data set (crystal 1). The availability of several homologous -k-ACPR structures in the Protein Data Bank suggested MR as the method of choice for structure solution. The CaspR webserver for automated MR using homology modeling was used (Claude et al., 2004) , with a search for two subunits in the asymmetric unit requested. The FabG homologues from P. falciparum (PDB code 2c07, chain A) and E. coli (PDB code 1q7b; chain A) were input as initial search models and for use in the automated homologymodeling routine. Both have $49% sequence identity to Aae FabG. Multiple sequence alignment identified three segments for truncation from the search models, corresponding to residues 1-6, 52-56 and 192-197 of the Aae FabG sequence. The best MR solution determined was with the truncated 1q7b monomer search model placed into the asymmetric unit as a dimer. This solution produced a c factor (the correlation coefficient calculated using |F obs | and |F calc |) of 55.8% and a conventional R factor of 47.1% using data in the resolution range 15.0-3.0 Å . Automated CNS refinement of this solution gave a final R of 36.7% and an R free of 44.3%. This refinement used the sequence of the truncated E. coli protein rather than the Aae FabG sequence. Initial analysis of the crystal structure reveals that Aae FabG is present as a tetramer comprised of a dimer within the asymmetric unit related to a second dimer by crystallographic twofold rotational symmetry. The tetrameric quaternary structure was as expected based upon the FabG-homologue crystal structures previously deposited in the PDB.
Conclusions
Aae FabG has been cloned and successfully expressed in E. coli. Good-quality diffraction data have been collected to 1.8 Å resolution and phasing has been performed by MR methods. Structure refinement is under way, as well as efforts to crystallize the enzyme-NADP cofactor complex. Previously, this protein has only been characterized by sequence analysis, which indicated that it is likely to participate in fatty-acid biosynthesis. We are interested in the structural/ functional aspects of this protein as part of a larger project aimed at identifying ensembles of co-varying residues, or fingerprints, that define SCOR subfamilies and are predictive of substrate and cofactor preference. Furthermore, this project aims to determine in detail the structural/functional role of these fingerprint residues.
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Figure 2
Crystals of Aae FabG grown via vapor diffusion in a hanging drop.
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